Search Results
Sep 09, 2026, 10:07 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therapeutics, Inc. Lawsuit - CAPR
suffered losses have until September 28, 2026 to seek appointment as lead plaintiff.Frequently Asked Questions About the CAPR LawsuitQ: How much did CAPR stock drop? A: Shares fell approximately 78.7%, a decline of an aggregate $15.08 per share across two corrective disclosures,
More news about: Levi & Korsinsky, LLP
Sep 09, 2026, 03:37 ET CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 08, 2026, 06:06 ET CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure
multimedia:https://www.prnewswire.com/news-releases/capr-lawsuit-alert-capricor-therapeutics-investors-face-september-28-deadline-after-64-stock-drop-tied-to-clinical-data-disclosure-302870584.htmlSOURCE
More news about: Bleichmar Fonti & Auld LLP
Sep 08, 2026, 02:12 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Sep 08, 2026, 02:08 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Sep 07, 2026, 13:22 ET Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
LLP—a national plaintiffs' rights law firm with a premier securities practice group—notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This alert follows the U.S. Food and Drug
More news about: Hagens Berman Sobol Shapiro LLP
Sep 04, 2026, 22:00 ET Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR), if they purchased Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). This action is pending in the United
More news about: ClaimsFiler
Sep 04, 2026, 13:45 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-capr-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302869668.htmlSOURCE
More news about: Glancy Prongay Wolke & Rotter LLP
Sep 04, 2026, 08:18 ET CAPR DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. (""Capricor" or the "Company") (NASDAQ: CAPR) and reminds investors of the September 28, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Sep 03, 2026, 16:54 ET CAPR Stock Alert: Capricor Therapeutics, Inc. Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman
LLP—a national plaintiffs' rights law firm with a premier securities practice group—notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This alert follows the U.S. Food and Drug
More news about: Hagens Berman Sobol Shapiro LLP
Sep 03, 2026, 16:50 ET CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 12:00 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
action lawsuit against Capricor Therapeutics, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CAPRICOR THERAPEUTICS, INC. (CAPR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE SEPTEMBER 28, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD
More news about: Law Offices of Howard G. Smith
Sep 03, 2026, 10:11 ET CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt
securities litigation firms in the United States.Frequently Asked Questions About the CAPR LawsuitQ: Who is eligible to join the CAPR investor lawsuit? A: Investors who purchased CAPR stock or securities between December 17, 2025 and July 26, 2026 and suffered financial losses
More news about: SueWallSt.com
Sep 03, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Sep 03, 2026, 05:55 ET CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - September 28, 2026 Deadline
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appointment as
More news about: Robbins Geller Rudman & Dowd LLP
Sep 03, 2026, 04:03 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Sep 03, 2026, 03:57 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Sep 02, 2026, 12:20 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Capricor Therapeutics, Inc. (CAPR) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Sep 02, 2026, 10:07 ET CAPR Deadline Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026
28, 2026 to seek appointment as lead plaintiff.Frequently Asked Questions About the CAPR LawsuitQ: Who is eligible to join the CAPR investor lawsuit? A: Investors who purchased CAPR stock or securities between December 17, 2025 and July 26, 2026 and suffered financial losses
More news about: Levi & Korsinsky, LLP
Sep 01, 2026, 12:00 ET INVESTOR DEADLINE: Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
LLP—a national plaintiffs' rights law firm with a premier securities practice group—notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This alert follows the U.S. Food and Drug
More news about: Hagens Berman Sobol Shapiro LLP
Sep 01, 2026, 06:22 ET CAPR Class Action Alert: Capricor Therapeutics Clinical Data Issues and Subsequent 64% Stock Drop Lead to Investor Securities Fraud Class Action to Recover Losses
multimedia:https://www.prnewswire.com/news-releases/capr-class-action-alert-capricor-therapeutics-clinical-data-issues-and-subsequent-64-stock-drop-lead-to-investor-securities-fraud-class-action-to-recover-losses-302865681.htmlSOURCE
More news about: Bleichmar Fonti & Auld LLP
Aug 31, 2026, 21:03 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Aug 31, 2026, 03:30 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 31, 2026, 03:24 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 28, 2026, 22:00 ET Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC